1. Scrip

Sawai Urges Japan To Take 'Best And Only Chance' To Reform Pricing Amid Generic Crisis

 
• By Lisa Takagi

Kenzo Sawai, president of Japanese generics giant Sawai Pharmaceutical, tells Scrip in the first of a two-part exclusive interview about the firm’s strategy and backstory of efforts to maintain product supplies amid the country’s ongoing generic crisis. He also urges Japan to take "the best and only chance" to reform its drug pricing system to help the entire market survive.

Kenzo Sawai, president of Sawai Pharmaceutical answered to Scrip's exclusive interview on 22 Jun, 2022
Kenzo Sawai, president of Sawai Pharmaceutical • Source: Lisa Takagi

“The damage caused by a couple of players in the generic industry ended up blocking other players’ distribution in its course of recovery.”

Describing the generics crisis that has been haunting Japan's pharmaceutical industry for more than a year, Kenzo Sawai, president of one of the country’s biggest firms in the sector, Sawai Pharmaceutical Co., Ltd

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Japan

More from Focus On Asia